Literature DB >> 8416687

In vivo magnetic resonance spectroscopy of human brain tumors.

P B Barker1, J D Glickson, R N Bryan.   

Abstract

In vivo nuclear magnetic resonance (NMR) spectroscopy is a rapidly developing, noninvasive analytical technique that allows sequential studies of brain tumor metabolism. It can be implemented on most conventional high-field magnetic resonance imaging scanners. In animal tumor models, NMR spectroscopy has been used extensively to characterize the metabolic changes associated with tumor growth and response to therapy. Preliminary data in humans indicate the feasibility of recording phosphorus and proton spectra from focal lesions within the brain. It is hoped that the technique will provide useful prognostic information in terms of tumor growth behavior and prediction and detection of response to therapy. However, the technique suffers from relatively coarse spatial resolution, and the methodology is still under development. More studies with larger patient groups are required before the clinical utility of the technique can be fully evaluated.

Entities:  

Mesh:

Year:  1993        PMID: 8416687

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  13 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.

Authors:  A Aria Tzika; Maria K Zarifi; Liliana Goumnerova; Loukas G Astrakas; David Zurakowski; Tina Young-Poussaint; Douglas C Anthony; R Michael Scott; Peter McL Black
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

Review 3.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

5.  Proton MRS imaging in pediatric brain tumors.

Authors:  Maria Zarifi; A Aria Tzika
Journal:  Pediatr Radiol       Date:  2016-05-27

6.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

Authors:  H Shimizu; T Kumabe; R Shirane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 7.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

8.  3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.

Authors:  J-h Kim; K-H Chang; D G Na; I C Song; B J Kwon; M H Han; K Kim
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

9.  Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells.

Authors:  Ahmet T Baykal; Mohit R Jain; Hong Li
Journal:  Metabolomics       Date:  2008-12-01       Impact factor: 4.290

10.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.